June 26, 2009 – EndoBarrier ™ Gastrointestinal Liner Plus Flow Restrictor Facilitates Substantial Excess Weight Loss; Median %EWL of 39.6 Percent - GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, announced results from a pilot clinical study which demonstrated the substantially enhanced weight loss effects of combining the company’s EndoBarrier Gastrointestinal Liner with a new EndoBarrier Flow Restrictor. The EndoBarrier Flow Restrictor provides an adjustable restriction at the outlet of the stomach and is designed to delay gastric emptying, an additional mechanism which adds to the therapeutic effects of the liner. The results were presented at the 26th annual meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS)... (Word) GI Dynamics' Press Release -
Saturday, July 25, 2009
GI Dynamics : Novel Non-Surgical Therapy Dramatically Increases Weight Loss in Obese Patients; Results from Pilot Clinical Study Presented at ASMBS
June 26, 2009 – EndoBarrier ™ Gastrointestinal Liner Plus Flow Restrictor Facilitates Substantial Excess Weight Loss; Median %EWL of 39.6 Percent - GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, announced results from a pilot clinical study which demonstrated the substantially enhanced weight loss effects of combining the company’s EndoBarrier Gastrointestinal Liner with a new EndoBarrier Flow Restrictor. The EndoBarrier Flow Restrictor provides an adjustable restriction at the outlet of the stomach and is designed to delay gastric emptying, an additional mechanism which adds to the therapeutic effects of the liner. The results were presented at the 26th annual meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS)... (Word) GI Dynamics' Press Release -
